Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?VALUE IN HEALTHIF62020-03-016OAAI
An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility ValuesAPPLIED HEALTH ECONOMICS AND HEALTH POLICYIF3.32019-04-0375OAAI
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force ReportVALUE IN HEALTHIF62019-03-01118OAAI
Predicting Productivity Losses from Health-Related Quality of Life Using Patient DataAPPLIED HEALTH ECONOMICS AND HEALTH POLICYIF3.32017-03-315OAAI
A model for measuring the health burden of classic congenital adrenal hyperplasia in adultsCLINICAL ENDOCRINOLOGYIF2.42016-04-089OA
USING FACT DATA TO PREDICT PREFERENCE-BASED UTILITY MEASURES FOR PEOPLE WITH MALIGNANT MELANOMA: A REVIEW OF THE EVIDENCEVALUE IN HEALTHIF62015-05-010OAAI
A SYSTEMATIC REVIEW AND CRITICAL APRAISAL OF ECONOMIC EVALUATIONS OF RADIOTHERAPY FOR CANCERVALUE IN HEALTHIF62013-11-010OAAI
ECONOMIC EVIDENCE OF SURGICAL PROCEDURES IN CANCER: A SYSTEMATIC LITERATURE REVIEWVALUE IN HEALTHIF62013-11-010OAAI
Association between body mass index and health-related quality of life, and the impact of self-reported long-term conditions - cross-sectional study from the south Yorkshire cohort datasetBMC PUBLIC HEALTHIF3.62013-10-2548OAAI
Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health TechnologiesVALUE IN HEALTHIF62012-09-0149OAAI
Estimating Health State Utility Values for Joint Health Conditions: A Conceptual Review and Critique of the Current EvidenceMEDICAL DECISION MAKINGIF2.32012-08-2723PREAI
Principles of health economic evaluations of lipid-lowering strategiesCURRENT OPINION IN LIPIDOLOGYIF4.62012-08-015PREAI
Tails from the Peak District: Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility ValuesVALUE IN HEALTHIF62012-05-01123OAAI
Comparing EQ-5D Scores for Comorbid Health Conditions Estimated Using 5 Different MethodsMEDICAL CAREIF2.82012-05-0127PRE
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic reviewHEALTH TECHNOLOGY ASSESSMENTIF42012-02-0152OA
A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesityOBESITY REVIEWSIF7.42012-01-3041OA
ESTIMATING SF-6D HEALTH STATE UTILITY VALUES FOR COMORID HEALTH CONDITIONSVALUE IN HEALTHIF62011-11-010OAAI
MODELLING EQ-5D HEALTH STATE VALUES: DEVELOPING A LIMITED DEPENDENT VARIABLE, MIXTURE MODELING APPROACHVALUE IN HEALTHIF62011-11-010OAAI
MODELLING THE COST-EFFECTIVENESS OF ORLISTAT AS A TREATMENT FOR OBESITY IN PRIMARY CAREVALUE IN HEALTHIF62011-11-012OAAI
ARE GENERAL POPULATION DATA SUITABLE FOR APPROXIMATING BASELINE UTILITY VALUES IN ECONOMIC MODELS?VALUE IN HEALTHIF62011-11-010OAAI